| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4c53f0e5cd84831055aaf13eaa2a6cfe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb75a92251c917a427ced57f7f525cb5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_71499ee5cbc2e0ef0934e4f106318743
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8434b61041b707e1e73f03acad946297 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-32 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2008-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cc381ad15ef1bc237a5efbda1431e4f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d12ad5c6ce77d03fc6650ea38ca0e03a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06b6db2e5367156e59486f8690884b2f |
| publicationDate |
2008-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2008116083-A1 |
| titleOfInvention |
Use of ranolazine for elevated brain-type natriuretic peptide |
| abstract |
This invention is directed to the use of ranolazine to reduce the risk of adverse coronary events in a mammalian patient. Typically, the natriuretic peptide is associated with coronary disease, acute coronary syndrome, and/or diastolic dysfunction. Ranolazine may be administered to the patient as an intravenous solution or in an oral dose. |
| priorityDate |
2007-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |